RA Capital Healthcare Fund LP, 10% Owner at AN2 Therapeutics, Inc. (ANTX), sold 7,050,188 shares at $1.08 ($7.6M) on 2024-08-09, disclosed to the SEC on 2024-08-13.
Open-market sale of $7.6M ANTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.08 | 114,759 | $124K | 1.6% |
| 2 | $1.08 | 114,759 | $124K | 1.6% |
| 3 | $1.08 | 3,410,335 | $3.7M | 48.4% |
| 4 | $1.08 | 3,410,335 | $3.7M | 48.4% |
| Total | $1.08 avg | 7,050,188 | $7.6M | 100% |
| Filing → |
| FULC | SELL | 2025-12-10 | $116.8M | — | Filing → |
| PEPG | BUY | 2025-09-30 | $30.0M | — | Filing → |
| TYRA | BUY | 2025-06-11 | $3.8M | — | Filing → |